Clinical trial
Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical…
NCT00005623 · Barr Laboratories, Industry · Completed
Key facts
| NCT number | NCT00005623 |
|---|---|
| Title | Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer |
| Official title | A Phase III, Randomized, Multicenter, Placebo-Controlled, Double-Blind Clinical Trial to Study the Efficacy and Safety of CyPat (Cyproterone Acetate [CA]) for the Treatment of Hot Flashes Following Surgical or Chemical Castration of Prostate Cancer Patients and Its Impact on the Quality of Life in… |
| Lead sponsor | Barr Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hot Flashes, Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cyproterone acetate, quality-of-life assessment |
| Start date | Dec 1, 1999 |
| Completion | Jan 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: